NCT01850810已完成不适用
Evaluation of a Nutritional Product for People With Type 2 Diabetes (T2DM)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 33
- 试验地点
- 3
- 主要终点
- Hunger
研究概览
简要总结
The objective of this trial is to evaluate a nutritional product for people with Diabetes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects will be eligible for the study if they meet all of the following inclusion criteria:
- •Diagnosis of Type 2 Diabetes.
- •Age between 18 and 75 years.
- •HbA1c > 6.0 but ≤ 8.5
- •If female and of childbearing potential , subject is non-pregnant, non- lactating, at least 6 weeks postpartum and agrees to practice birth control throughout study duration.
- •BMI is > 18.5 kg/m2 and < 40.0 kg/m
- •Chronic medication dosage must be stable for at least two months prior to Screening Visit.
- •Subject states that they are a habitual consumer of a morning meal.
排除标准
- •Subjects will be excluded from the study if they meet any of the following criteria:
- •Use of exogenous insulin or GLP-1 agonists for glucose control.
- •Diagnosis of Type 1 diabetes.
- •History of diabetic ketoacidosis.
- •Current infection (requiring medication or hospitalization), has received corticosteroid treatment in the last 3 months, or has had surgery or received antibiotics in the last 3 weeks.
- •Active malignancy.
- •Significant cardiovascular event < 12 weeks prior to study entry.
- •End stage organ failure or status post organ transplant.
- •Active metabolic, hepatic, or gastrointestinal disease.
- •Chronic, contagious, infectious disease.
- •Currently taking herbals, dietary supplements, or medications (other than antihyperglycemic medications) that could profoundly affect blood glucose.
- •History of fainting or other adverse reactions in response to blood collection.
- •Clotting or bleeding disorders.
- •Allergy or intolerance to study product ingredient.
结局指标
主要结局
Hunger
时间窗: Treatment Visit Week 1 and Treatment Visit Week 2
An appetite questionnaire administered 0 to 300 minutes during each study visit.
次要结局
- Desire to Eat(Treatment Visit Week 1 and Treatment Visit Week 2)
- Prospective Consumption(Treatment Visit Week 1 and Treatment Visit Week 2)
- Fullness(Treatment Visit Week 1 and Treatment Visit Week 2)
研究者
研究点 (3)
Loading locations...
相似试验
撤回
不适用
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.DiabetesNCT01850134Abbott Nutrition
已完成
不适用
Eat Well Produce Benefit for Diabetes and Food InsecurityFood InsecurityDiabetes MellitusNCT05896644Duke University2,177
已完成
不适用
A Study to Evaluate Glucose and Insulin Response to NutralinDiabetesNCT01275820Avera McKennan Hospital & University Health Center10
已完成
不适用
Prebiotic Effects on Glucose ToleranceDiet Prevention of Metabolic DiseasesNCT03944343Lund University19
已完成
不适用
To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.Diabetic NeuropathiesInsomnia Due to Medical ConditionNCT04504305Vedic Lifesciences Pvt. Ltd.64